TotalMarketCap

Xilio Therapeutics

XLONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$55.931 M

$8.50 -1.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Xilio Therapeutics (XLO) has a market capitalization of $55.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$43.8M

#2759 by revenue

Earnings

-$35.0M

Loss-making

Shares outstanding

5,782,511

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #324Nomad Power SolutionsNMAD$56.4M
  2. #325CleneCLNN$56.2M
  3. #326Xilio TherapeuticsXLO$55.9M
  4. #327Boundless BioBOLD$55.8M
  5. #328RafaelRFL$55.3M

What if Xilio Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,291,221

Per share 504,850× higher

Bitcoin $1.53T

$232,190.50

Per share 27,317× higher

Apple $5.02T

$762,259.73

Per share 89,678× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Xilio Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.